Drug intelligence / Profile preview

APH-1502

Development stage: Preclinical
Lead developer: Aphios Pharma
Modality: Nanoparticles → Drug Delivery Systems, Small Molecules
Administration: Oral, Injectable

Overview

APH-1502 is a nanoparticle formulation of cannabidiol (CBD) being developed by Aphios Pharma for the treatment of chemotherapy-induced peripheral neuropathic pain (CIPNP). The drug utilizes Aphios' patented SuperFluids Polymer Nanospheres (SFS-PNS) technology to encapsulate CBD in biodegradable polymer nanoparticles, which is designed to enhance bioavailability and provide extended-release properties. APH-1502 targets the CB1 and CB2 cannabinoid receptors to modulate pain signaling, offering a potential non-opioid alternative for managing neuropathic pain with improved control and reduced systemic side effects. It is currently in the preclinical stage of development as part of a pipeline of extended-release cannabinoid nanotherapies.

Other names: APH-1502 CBD nanoparticlesAPH1502 CBD nanoparticlesAPH 1502 CBD nanoparticles

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on APH-1502.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on APH-1502.

Explore the full profile